Indeed, a new model of SCLC nomenclature defined by the differential expression of four key-transcription regulators (ASCL1, NEUROD1, YAP1 and POU2F3) has just been recently presented and validated in surgically resected samples.11 The gene discussed is POU2F3; the disease is small cell lung carcinoma.